15058
home,page-template,page-template-full_width,page-template-full_width-php,page,page-id-15058,bridge-core-3.2.0,qi-blocks-1.3.1,qodef-gutenberg--no-touch,qodef-qi--no-touch,qi-addons-for-elementor-1.7.8,qode-page-transition-enabled,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-30.6.1,qode-theme-bridge,wpb-js-composer js-comp-ver-7.9,vc_responsive,elementor-default,elementor-kit-7

Realizing the opportunity of glial targeted medicines

We believe that medicines targeting glial cells represent an unrecognized opportunity to treat neurological diseases. Realizing this opportunity is our mission. To do this we are designing advanced cellular platforms that can be used, in combination with unbiased chemical and genetic screening approaches, to identify proteins and pathways that regulate pathological glial cell function and can be developed as targets of glial targeted medicines.